Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Hamada

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Anticancer Research|April 28, 2026
Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP GradeKosuke Hamada, Takeshi Yamasaki, Chisato Ohe, et al.
Urology|January 30, 2022
Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual ImagingKasumi Kaneko Yoshitomi, Yoshinobu Komai, Tatsuya Yamamoto, et al.
International Journal of Clinical Oncology|June 12, 2021
External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancerEri Fukagawa, Shinya Yamamoto, Sachiko Ohde, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Anticancer Research|April 28, 2026
Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP GradeKosuke Hamada, Takeshi Yamasaki, Chisato Ohe, et al.
Urology|January 30, 2022
Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual ImagingKasumi Kaneko Yoshitomi, Yoshinobu Komai, Tatsuya Yamamoto, et al.
International Journal of Clinical Oncology|June 12, 2021
External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancerEri Fukagawa, Shinya Yamamoto, Sachiko Ohde, et al.
Pageof 3